IP Library Assignment 056206/0266
Patent Assignment
Reel/Frame 056206/0266

Security Interest

Recorded: 2021-05-11 Pages: 9
Assignor
MARINUS PHARMACEUTICALS, INC.
Executed: 2021-05-11
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FL., LOS ANGELES, CALIFORNIA, 90071
Covered Properties (20)
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,022,054 →
Application: 11/605,700 →
Publication: US 2007/0141161
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 7,858,609 →
Application: 11/606,222 →
Publication: US 2007/0148252
Method for Making 3A-Hydroxy, 3B- Substituted-5A-Pregnan-20-Ones
Patent: 8,362,286 →
Application: 12/854,226 →
Publication: US 2011/0040112
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,367,651 →
Application: 13/052,798 →
Publication: US 2011/0236487
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,318,714 →
Application: 13/217,384 →
Publication: US 2012/0052098
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 9,056,116 →
Application: 13/657,135 →
Publication: US 2013/0287851
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,618,087 →
Application: 13/719,640 →
Publication: US 2013/0156821
Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
Patent: 9,029,355 →
Application: 14/087,903 →
Publication: US 2014/0154309
Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
Patent: 9,452,176 →
Application: 14/709,062 →
Publication: US 2015/0313843
Injectable Neurosteroid Formulations Containing Nanoparticles
Application: 15/294,135 →
Publication: US 2017/0258812
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 15/700,314 →
Publication: US 2018/0071315
Method of Treatment Using Nanoparticulate Ganaxolone Formulations
Application: 16/149,970 →
Publication: US 2019/0117674
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 16/150,782 →
Publication: US 2019/0167698
Ganaxolone for Use in Prophylaxis and Treatment of Pospartum Depression
Application: 16/705,541 →
Publication: US 2020/0179403
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 16/829,661 →
Publication: US 2020/0289530
Injectable Neurosteroid Formulations Containing Nanoparticles
Application: 16/992,873 →
Publication: US 2021/0128583
Ganaxolone for Use in Treating Genetic Epileptic Disorders
Application: 17/065,174 →
Ganaxolone for Use in Treatment of Status Epilepticus
Application: 17/186,569 →
Publication: US 2021/0186987
Ganaxolone for Use in Treatment of Super Refractory Status Epilepticus
Application: 63/117,037 →
Use of Ganaxolone in Treating an Epilepsy Disorder
Application: 63/122,378 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 28, 2006
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 018638/0982 →
Assignment of Assignor's Interest Nov 29, 2006
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 018630/0213 →
Assignment of Assignor's Interest Sep 17, 2010
From: SHAW, KENNETH; HUTCHISON, ALAN
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 025004/0272 →
Assignment of Assignor's Interest Oct 3, 2012
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 029071/0854 →
Assignment of Assignor's Interest Jan 9, 2013
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 029592/0851 →
Assignment of Assignor's Interest Mar 17, 2014
From: KENNETH, SHAW; MINGBAO, ZHANG
To: MARINUS PHARMACEUTICALS
Reel/Frame 032452/0914 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036938/0243 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036937/0986 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036938/0189 →
Assignment of Assignor's Interest Nov 16, 2016
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.; CZEKAI, DAVID
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 040340/0312 →
Assignment of Assignor's Interest Jun 19, 2018
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 046132/0787 →
Assignment of Assignor's Interest Feb 26, 2020
From: AIMETTI, ALEX; CASHMAN, CHRISTOPHER; MASUOKA, LORIANNE; LAPPALAINEN, JAAKKO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 051941/0460 →
Assignment of Assignor's Interest Mar 20, 2020
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 052177/0703 →
Assignment of Assignor's Interest Jun 3, 2020
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 052827/0472 →
Assignment of Assignor's Interest Oct 8, 2020
From: MASUOKA, LORIANNE K.; LAPPALAINEN, JAAKKO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 054007/0415 →
Assignment of Assignor's Interest Jan 6, 2021
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.; CZEKAI, DAVID
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 054832/0494 →
Assignment of Assignor's Interest Mar 10, 2021
From: CZEKAI, DAVID; GASIOR, MACIEJ; MASUOKA, LORIANNE; TSAI, JULIA
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 055555/0867 →
Assignment of Assignor's Interest Jun 21, 2021
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 056608/0740 →
Corrective Assignment to Correct the Receiving Party Should Be Marinus Pharmaceuticals, Inc. Previously Recorded at Reel: 029071 Frame: 0854. Assignor(S) Hereby Confirms the Assignment. Feb 28, 2022
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 059618/0570 →
Security Interest Oct 28, 2022
From: MARINUS PHARMACEUTICALS, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 061580/0171 →
Release of Security Interest Feb 13, 2025
From: SAGARD HEALTHCARE PARTNERS FUNDING COMPANY SPE 1, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070204/0035 →
Release of Security Interest Feb 20, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070278/0496 →
Change of Name May 14, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071116/0534 →
Change of Name May 14, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071116/0191 →
Change of Name May 14, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071115/0973 →